Intraoperative identification of suspicious palpable lymph nodes as an integral part of sentinel node biopsy in patients with breast cancer

Surgery Today

Volumn 38, Issue 5, 2008, Pages 390-394

  Choi, Young Jin ^a   Kim, Jung Han ^a   Nam, Seok Jin ^a   Ko, Young Hyeh ^a   Yang, Jung Hyun ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Breast cancer; False negative rates; Sentinel lymph node biopsy; Suspicious palpable lymph node biopsy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MEDICAL RECORD; PALPATION; SAMPLING; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; STAINING;

ADULT; AGED; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; INTRAOPERATIVE CARE; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; SENTINEL LYMPH NODE BIOPSY;

EID: 43049110248     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-007-3653-y     Document Type: Article

References (16)

1. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-1867.
2. O'Hea BJ, Hill AD, El-Shirbiny AM, Yeh SD, Rosen PP, Coit DG, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998;186:423-427.
3. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006;98:599-609.
4. Kelley MC, Hansen N, McMasters KM. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Am J Surg 2004;188:49-61.
5. Martin RC, 2nd, Chagpar A, Scoggins CR, Edwards MJ, Hagendoorn L, Stromberg AJ, et al. Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg 2005;241:1005-1012; discussion 12-5.
6. White RL Jr, Wilke LG. Update on the NSABP and ACOSOG breast cancer sentinel node trials. Am Surg 2004;70:420-424.
7. Martin RC, Fey J, Yeung H, Borgen PI, Cody HS 3rd. Highest isotope count does not predict sentinel node positivity in all breast cancer patients. Ann Surg Oncol 2001;8:592-597.
8. Tanis PJ, Nieweg OE, Merkus JW, Peterse JL, Kroon BB. False negative sentinel node procedure established through palpation of the biopsy wound. Eur J Surg Oncol 2000;26:714-715.
9. Carmon M, Olsha O, Rivkin L, Spira RM, Golomb E. Intraoperative palpation for clinically suspicious axillary sentinel lymph nodes reduces the false-negative rate of sentinel lymph node biopsy in breast cancer. Breast J 2006;12:199-201.
10. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-466.
11. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
12. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-398; discussion 8-401.
13. Bergkvist L, Frisell J. Multicentre validation study of sentinel node biopsy for staging in breast cancer. Br J Surg 2005;92:1221-1224.
14. Goyal A, Newcombe RG, Chhabra A, Mansel RE. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer - results of the ALMANAC validation phase. Breast Cancer Res Treat 2006;99:203-208.
15. Nieweg OE, Estourgie SH. What is a sentinel node and what is a false-negative sentinel node? Ann Surg Oncol 2004;11:169S-173S.
16. Martin RC, Derossis AM, Fey J, Yeung H, Yeh SD, Akhurst T, et al. Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer. Surgery 2001;130:432-438.